Eli Lilly’s Obesity Momentum Faces Another Earnings Test

Eli Lilly (NYSE: LLY) is scheduled to report second-quarter results before the market opens on Wednesday, Aug. 5, with investors looking for another strong quarter driven by continued demand for its blockbuster diabetes and obesity medicines. Wall Street expects the

Eli Lilly (NYSE: LLY) is scheduled to report second-quarter results before the market opens on Wednesday, Aug. 5, with investors looking for another strong quarter driven by continued demand for its blockbuster diabetes and obesity medicines.

Wall Street expects the

Leave a Reply

Your email address will not be published. Required fields are marked *